What is the latest on Capitol Hill with respect to the coronavirus? GT’s Federal Government Law & Policy practice is hosting a series of webinars featuring Members of Congress to provide timely developments from Capitol Hill during the COVID-19 pandemic.Join Representative Tim Ryan (D-OH), and GT’s former Members of Congress Rodney Frelinghuysen (R-NJ) and Albert
What is the latest on Capitol Hill with respect to the coronavirus? GT’s Federal Government Law & Policy practice is hosting a series of webinars featuring Members of Congress to provide timely developments from Capitol Hill during the COVID-19 pandemic.Join Representative Tom Cole (R-OK), House Deputy Minority Whip, and GT’s former Members of Congress Rodney
What is the latest on Capitol Hill with respect to the coronavirus? GT’s Federal Government Law & Policy practice is hosting a series of webinars featuring Members of Congress to provide timely developments from Capitol Hill during the COVID-19 pandemic. Hear from bipartisan Congressional leadership in our first two webinars of the series featuring Representative
The Coronavirus Aid, Relief, and Economic Security (CARES) Act, passed by Congress and signed into law by President Trump on March 27, 2020, includes several provisions offering support for U.S. agribusiness, ranchers, and farmers. Overall the legislation includes roughly $49 billion in funding for crop and livestock producers, nutrition assistance, and support for local producers
On Friday, Nov. 1, and as discussed in a previous Hot Off the Hill blog post, President Trump nominated Dr. Stephen Hahn, Chief Executive of the MD Anderson Cancer Center, for FDA Commissioner.
HHS Secretary Alex Azar also announced leadership changes to complement the president’s announcement.
This action brings significant executive leadership change into
Due to federal rules applicable to “acting” agency heads, the current FDA Acting Commissioner, Ned Sharpless, or another person, should be nominated to be FDA Commissioner by month’s end. In order to be named FDA Commissioner, Senate confirmation is required.
This is a critical time for FDA as they face the ongoing fiscal